Ginkgo Bioworks Holdings, Inc.
DNA
$6.79
-$0.45-6.22%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.54% | 9.20% | 24.91% | -43.18% | 72.24% |
| Total Depreciation and Amortization | -15.09% | -19.05% | -18.16% | -95.66% | -6.18% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 5.26% | -23.53% |
| Total Other Non-Cash Items | -88.70% | 18.48% | -9.04% | -37.22% | -73.60% |
| Change in Net Operating Assets | 45.53% | -106.95% | -1,182.47% | 114.05% | -510.43% |
| Cash from Operations | -9.98% | 9.38% | -12.36% | 69.46% | 52.30% |
| Capital Expenditure | -6,792.11% | 74.64% | 99.96% | 100.00% | 99.86% |
| Sale of Property, Plant, and Equipment | -- | -- | 907.02% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 121.47% | 113.12% | 16,542.61% | -1,794.18% | -33,529.32% |
| Cash from Investing | 117.35% | 111.64% | 826.78% | -613.88% | -138.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 90.82% | 87.68% | 88.00% | 51.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -33.96% | -- |
| Cash from Financing | 16,925.51% | 90.82% | 4,110.84% | 2,237.20% | 56.64% |
| Foreign Exchange rate Adjustments | -76.88% | -274.32% | -108.22% | 365.71% | 1,262.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.99% | 90.53% | 199.31% | 17.35% | 6.66% |